LabCompass

Parvathi Sudha

Medicine · Indiana University

Publications

116

Citations

561

Est. group size

~2

Recurring co-author estimate

Active years

19

Publishing since 2007

Research summary
AI-generated

Parvathi Sudha's research spans molecular and cellular biology in medicine, with work on how genes and signaling pathways control lung cell development and function, as well as studies of cancers such as rhabdomyosarcoma, lung adenocarcinoma, and rare conditions like lymphangioleiomyomatosis. Several studies use single-cell RNA sequencing to map how different cell types behave and change, for example in the lung at birth. More recent bibliographic topics also point toward blood cancer (multiple myeloma) and immunotherapy research.

Lung development and epithelial cell differentiationSingle-cell RNA sequencing and cellular heterogeneityCancer biology (rhabdomyosarcoma, lung adenocarcinoma)Rare disease research (lymphangioleiomyomatosis)Immuno-oncology and immunotherapy

Publication activity has grown substantially over the past decade, rising from a few papers per year up to 2021 to a sharp increase in 2023 and continuing at a high level.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 19.4/year recently
172018: 2 publications182019: 3 publications192020: 4 publications202021: 5 publications212022: 7 publications222023: 56 publications56232024: 7 publications242025: 27 publications2526
Recent publications
Publishes in
  • Blood×15
  • Clinical Lymphoma Myeloma & Leukemia×6
  • Nature Communications×2
  • Blood Cancer Journal×2
  • bioRxiv (Cold Spring Harbor Laboratory)×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile